• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Dexcom G6 picks up coverage expansion in Canada

April 27, 2023 By Sean Whooley

Dexcom G6 in action
The Dexcom G6. [Image courtesy of Dexcom]
Dexcom (Nasdaq:DXCM) today said it applauds an expansion of coverage for continuous glucose monitoring (CGM) systems in Canada.

The coverage expansion comes through the Non-Insured Health Benefits (NIHB) program. It now enables any client managing diabetes with insulin to access the standard of care.

Dexcom said its G6 CGM is now at its most accessible point ever under the NIHB program. It marks the highest degree of diabetes management possible for First Nations and Inuit peoples. According to the company, the expansion brings people in Canada one step closer to accessing the technology they need.

“The Non-Insured Health Benefits program ensures that First Nations and Inuit peoples across the country have accessible health benefits and coverage for critical diabetes supports,” said Dr. Jeff Winterstein, an Edmonton-based internal medicine specialist who works with many NIHB clients.

This expansion in Canada follows a major Medicare coverage win in the U.S. for Dexcom and CGM makers alike. Earlier this year, the company had another Canadian coverage win, too. Dexcom said in March that all people with type 1 and type 2 diabetes in Manitoba, Canada, meet eligibility criteria for its G6 CGM.

“In line with the impressive coverage expansion from Centers for Medicare & Medicaid Services (CMS) in the United States, NIHB’s decision to expand coverage for real-time CGM to any client using insulin is a crucial sign of forward motion within Canada’s healthcare system and will pave the way for improved health and quality of life outcomes,” said André Côté, VP and GM of Dexcom Canada. “We are thrilled that more First Nations and Inuit peoples will gain access to Dexcom G6 and benefit from its transformative features, which is the standard of care for every person living with diabetes.”

About the Dexcom G6

The Dexcom G6 features a small, wearable sensor and transmitter that continuously measures glucose. It transmits glucose levels wirelessly to a smart device or receiver. The system enables patients to evaluate real-time data without scanning or pricking their finger routinely.

Dexcom’s system offers customizable and predictive alerts and an urgent low alarm to help avoid hypoglycemic events. The G6 app also allows patients to share glucose information with up to 10 followers. Dexcom said it allows family, loved ones and healthcare providers to remotely monitor patients.

Health Canada approved the G6 for people with diabetes ages two and up in early 2019. It’s remained one of the leading CGM systems around the world since its introduction. The next-generation Dexcom G7 received U.S. FDA approval in December 2022 but has yet to receive Canadian authorization.

Dexcom G6 also offers connectivity through integrations with insulin delivery systems and digital health apps.

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: Dexcom

IN CASE YOU MISSED IT

  • Dexcom updates CGM receiver recall that led to serious adverse events
  • Abbott reports momentum with Libre CGM business as new dual sensor will ‘accelerate’ growth
  • Johnson & Johnson wins FDA priority review for drug delivery system
  • Glucose monitoring company LifeScan files chapter 11 to reduce debt
  • Medtronic enrolls first patient in study for Onyx liquid embolic system

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS